BACKGROUND: There is lack of research on symptoms in patients with head and neck cancer in the palliative phase. The aim of this study was to explore symptom prevalence and the impact of these symptoms on daily functioning in patients with incurable head and neck cancer. Also, discrepancies between patients and family caregivers are described. METHODS: Questionnaires were used to collect data about symptom prevalence (n = 124) and symptom impact (n = 24). RESULTS: We discovered that the symptoms with a high prevalence were fatigue, pain, weakness, trouble with short walks outside, and dysphagia. The symptoms with the greatest impact on daily functioning were dyspnea, voice changes, trouble with short walks outside, anger, and weakness. CONCLUSIONS: Patients with incurable head and neck cancer experience a great number of different symptoms. Focus on these symptoms by health care professionals could further optimize symptom management. In future research, we recommend further validation of the used questionnaires.
BACKGROUND: There is lack of research on symptoms in patients with head and neck cancer in the palliative phase. The aim of this study was to explore symptom prevalence and the impact of these symptoms on daily functioning in patients with incurable head and neck cancer. Also, discrepancies between patients and family caregivers are described. METHODS: Questionnaires were used to collect data about symptom prevalence (n = 124) and symptom impact (n = 24). RESULTS: We discovered that the symptoms with a high prevalence were fatigue, pain, weakness, trouble with short walks outside, and dysphagia. The symptoms with the greatest impact on daily functioning were dyspnea, voice changes, trouble with short walks outside, anger, and weakness. CONCLUSIONS:Patients with incurable head and neck cancer experience a great number of different symptoms. Focus on these symptoms by health care professionals could further optimize symptom management. In future research, we recommend further validation of the used questionnaires.
Authors: Elise M Gane; Steven M McPhail; Anna L Hatton; Benedict J Panizza; Shaun P O'Leary Journal: Eur Arch Otorhinolaryngol Date: 2017-09-22 Impact factor: 2.503
Authors: Mellar P Davis; Lisa A Rybicki; Renato V Samala; Chirag Patel; Armida Parala-Metz; Ruth Lagman Journal: Support Care Cancer Date: 2021-01-21 Impact factor: 3.603
Authors: Bryce B Reeve; Sandra A Mitchell; Amylou C Dueck; Ethan Basch; David Cella; Carolyn Miller Reilly; Lori M Minasian; Andrea M Denicoff; Ann M O'Mara; Michael J Fisch; Cynthia Chauhan; Neil K Aaronson; Corneel Coens; Deborah Watkins Bruner Journal: J Natl Cancer Inst Date: 2014-07-08 Impact factor: 13.506
Authors: Catriona R Mayland; Kate Ingarfield; Simon N Rogers; Paola Dey; Steven Thomas; Andrea Waylen; Sam D Leary; Miranda Pring; Katrina Hurley; Tim Waterboer; Michael Pawlita; Andy R Ness Journal: Palliat Med Date: 2020-02-27 Impact factor: 4.762
Authors: Arta Hoesseini; Marinella P J Offerman; Bojou J van de Wall-Neecke; Aniel Sewnaik; Marjan H Wieringa; Robert J Baatenburg de Jong Journal: BMC Palliat Care Date: 2020-11-24 Impact factor: 3.234
Authors: Adrian W Midgley; Derek Lowe; Andrew R Levy; Vishal Mepani; Simon N Rogers Journal: Eur Arch Otorhinolaryngol Date: 2017-10-20 Impact factor: 2.503
Authors: Catriona Rachel Mayland; Hannah C Doughty; Simon N Rogers; Anna Gola; Stephen Mason; Cathy Hubbert; Dominic Macareavy; Barbara A Jack Journal: J Palliat Care Date: 2020-09-15 Impact factor: 2.250
Authors: Catriona R Mayland; Qiaoling Marilyn Ho; Hannah C Doughty; Simon N Rogers; Prithvi Peddinti; Praytush Chada; Stephen Mason; Matthew Cooper; Paola Dey Journal: Palliat Med Date: 2020-10-21 Impact factor: 4.762